nodes	percent_of_prediction	percent_of_DWPC	metapath
Imatinib—NTRK1—Amitriptyline—migraine	0.146	0.197	CbGbCtD
Imatinib—CA6—Topiramate—migraine	0.0474	0.0638	CbGbCtD
Imatinib—CA7—Topiramate—migraine	0.0413	0.0556	CbGbCtD
Imatinib—CA12—Topiramate—migraine	0.0354	0.0477	CbGbCtD
Imatinib—CA9—Topiramate—migraine	0.0354	0.0477	CbGbCtD
Imatinib—CA1—Topiramate—migraine	0.0332	0.0447	CbGbCtD
Imatinib—ORM1—Propranolol—migraine	0.0314	0.0423	CbGbCtD
Imatinib—CA2—Topiramate—migraine	0.0287	0.0386	CbGbCtD
Imatinib—ORM1—Amitriptyline—migraine	0.0271	0.0366	CbGbCtD
Imatinib—SLC22A2—Propranolol—migraine	0.0259	0.0349	CbGbCtD
Imatinib—SLC22A1—Verapamil—migraine	0.0155	0.0208	CbGbCtD
Imatinib—CYP3A7—Propranolol—migraine	0.0141	0.0191	CbGbCtD
Imatinib—CYP3A7-CYP3A51P—Propranolol—migraine	0.0141	0.0191	CbGbCtD
Imatinib—PTGS1—Valproic Acid—migraine	0.0139	0.0188	CbGbCtD
Imatinib—ABCG2—Verapamil—migraine	0.0131	0.0177	CbGbCtD
Imatinib—ALB—Amitriptyline—migraine	0.0114	0.0154	CbGbCtD
Imatinib—CYP3A5—Propranolol—migraine	0.0106	0.0143	CbGbCtD
Imatinib—CYP3A7—Verapamil—migraine	0.00971	0.0131	CbGbCtD
Imatinib—CYP3A7-CYP3A51P—Verapamil—migraine	0.00971	0.0131	CbGbCtD
Imatinib—CYP2C19—Timolol—migraine	0.0096	0.0129	CbGbCtD
Imatinib—CYP3A5—Amitriptyline—migraine	0.00918	0.0124	CbGbCtD
Imatinib—CYP2C19—Propranolol—migraine	0.00856	0.0115	CbGbCtD
Imatinib—CYP3A5—Valproic Acid—migraine	0.00836	0.0113	CbGbCtD
Imatinib—CYP1A2—Propranolol—migraine	0.0079	0.0106	CbGbCtD
Imatinib—ABCB1—Timolol—migraine	0.00775	0.0104	CbGbCtD
Imatinib—CYP2C19—Amitriptyline—migraine	0.0074	0.00997	CbGbCtD
Imatinib—CYP2D6—Timolol—migraine	0.0073	0.00983	CbGbCtD
Imatinib—CYP3A5—Verapamil—migraine	0.00728	0.00981	CbGbCtD
Imatinib—ABCB1—Propranolol—migraine	0.0069	0.0093	CbGbCtD
Imatinib—CYP1A2—Amitriptyline—migraine	0.00683	0.0092	CbGbCtD
Imatinib—CYP2C19—Valproic Acid—migraine	0.00675	0.00909	CbGbCtD
Imatinib—CYP2D6—Propranolol—migraine	0.00651	0.00876	CbGbCtD
Imatinib—CYP1A2—Valproic Acid—migraine	0.00622	0.00839	CbGbCtD
Imatinib—CYP2C9—Amitriptyline—migraine	0.00615	0.00829	CbGbCtD
Imatinib—CYP2C19—Topiramate—migraine	0.00609	0.0082	CbGbCtD
Imatinib—ABCB1—Amitriptyline—migraine	0.00597	0.00804	CbGbCtD
Imatinib—CYP2C19—Verapamil—migraine	0.00587	0.00791	CbGbCtD
Imatinib—CYP2D6—Amitriptyline—migraine	0.00563	0.00758	CbGbCtD
Imatinib—CYP2C9—Valproic Acid—migraine	0.00561	0.00756	CbGbCtD
Imatinib—CYP1A2—Verapamil—migraine	0.00542	0.0073	CbGbCtD
Imatinib—CYP2C9—Verapamil—migraine	0.00488	0.00658	CbGbCtD
Imatinib—ABCB1—Verapamil—migraine	0.00474	0.00638	CbGbCtD
Imatinib—CYP2D6—Verapamil—migraine	0.00447	0.00602	CbGbCtD
Imatinib—CYP3A4—Propranolol—migraine	0.00414	0.00557	CbGbCtD
Imatinib—CYP3A4—Amitriptyline—migraine	0.00358	0.00482	CbGbCtD
Imatinib—CYP3A4—Valproic Acid—migraine	0.00326	0.00439	CbGbCtD
Imatinib—CYP3A4—Topiramate—migraine	0.00294	0.00396	CbGbCtD
Imatinib—CYP3A4—Verapamil—migraine	0.00284	0.00383	CbGbCtD
Imatinib—NTRK1—trigeminal ganglion—migraine	0.00228	0.0416	CbGeAlD
Imatinib—ABCA3—trigeminal ganglion—migraine	0.0018	0.0329	CbGeAlD
Imatinib—DDR1—trigeminal ganglion—migraine	0.00166	0.0304	CbGeAlD
Imatinib—CA1—nerve—migraine	0.00113	0.0207	CbGeAlD
Imatinib—PIP4K2C—trigeminal ganglion—migraine	0.00103	0.0188	CbGeAlD
Imatinib—KIT—blood vessel—migraine	0.000974	0.0178	CbGeAlD
Imatinib—PDGFRB—blood vessel—migraine	0.000951	0.0174	CbGeAlD
Imatinib—LCK—trigeminal ganglion—migraine	0.000912	0.0166	CbGeAlD
Imatinib—ABCA3—head—migraine	0.000882	0.0161	CbGeAlD
Imatinib—ABCA3—nervous system—migraine	0.000836	0.0153	CbGeAlD
Imatinib—ABCA3—central nervous system—migraine	0.000805	0.0147	CbGeAlD
Imatinib—ABCA3—cerebellum—migraine	0.000787	0.0144	CbGeAlD
Imatinib—NQO2—trigeminal ganglion—migraine	0.000754	0.0138	CbGeAlD
Imatinib—DDR1—cerebellum—migraine	0.000726	0.0133	CbGeAlD
Imatinib—SLC22A2—trigeminal ganglion—migraine	0.000714	0.013	CbGeAlD
Imatinib—CA3—cardiovascular system—migraine	0.000708	0.0129	CbGeAlD
Imatinib—KIT—neck—migraine	0.000696	0.0127	CbGeAlD
Imatinib—PDGFRB—neck—migraine	0.00068	0.0124	CbGeAlD
Imatinib—NQO2—brainstem—migraine	0.000667	0.0122	CbGeAlD
Imatinib—CSF1R—trigeminal ganglion—migraine	0.000662	0.0121	CbGeAlD
Imatinib—HIPK4—brain—migraine	0.000646	0.0118	CbGeAlD
Imatinib—ABCA3—brain—migraine	0.000639	0.0117	CbGeAlD
Imatinib—SLC47A1—trigeminal ganglion—migraine	0.000605	0.011	CbGeAlD
Imatinib—KIT—trigeminal ganglion—migraine	0.000601	0.011	CbGeAlD
Imatinib—DDR1—brain—migraine	0.00059	0.0108	CbGeAlD
Imatinib—PDGFRB—trigeminal ganglion—migraine	0.000587	0.0107	CbGeAlD
Imatinib—PDGFRA—cardiovascular system—migraine	0.000543	0.00992	CbGeAlD
Imatinib—SLC47A1—brainstem—migraine	0.000535	0.00978	CbGeAlD
Imatinib—KIT—brainstem—migraine	0.000532	0.00972	CbGeAlD
Imatinib—ABL1—trigeminal ganglion—migraine	0.000524	0.00956	CbGeAlD
Imatinib—CA6—head—migraine	0.000506	0.00925	CbGeAlD
Imatinib—PIP4K2C—head—migraine	0.000502	0.00917	CbGeAlD
Imatinib—CA3—head—migraine	0.000479	0.00876	CbGeAlD
Imatinib—CSF1R—cardiovascular system—migraine	0.000478	0.00874	CbGeAlD
Imatinib—PIP4K2C—nervous system—migraine	0.000476	0.0087	CbGeAlD
Imatinib—ABL2—cerebellum—migraine	0.000474	0.00865	CbGeAlD
Imatinib—CA7—cerebellum—migraine	0.000466	0.00852	CbGeAlD
Imatinib—ABL1—brainstem—migraine	0.000463	0.00846	CbGeAlD
Imatinib—PIP4K2C—central nervous system—migraine	0.000458	0.00837	CbGeAlD
Imatinib—CA3—nervous system—migraine	0.000455	0.0083	CbGeAlD
Imatinib—PIP4K2C—cerebellum—migraine	0.000448	0.00818	CbGeAlD
Imatinib—PTGS1—blood vessel—migraine	0.000446	0.00814	CbGeAlD
Imatinib—CA3—central nervous system—migraine	0.000438	0.00799	CbGeAlD
Imatinib—KIT—cardiovascular system—migraine	0.000434	0.00793	CbGeAlD
Imatinib—PDGFRB—cardiovascular system—migraine	0.000424	0.00775	CbGeAlD
Imatinib—CA2—neck—migraine	0.000413	0.00754	CbGeAlD
Imatinib—CA9—cerebellum—migraine	0.00041	0.00748	CbGeAlD
Imatinib—CA1—cardiovascular system—migraine	0.000397	0.00726	CbGeAlD
Imatinib—CA14—cerebellum—migraine	0.000388	0.00709	CbGeAlD
Imatinib—ABL2—brain—migraine	0.000385	0.00702	CbGeAlD
Imatinib—CA7—brain—migraine	0.000379	0.00692	CbGeAlD
Imatinib—ABL1—cardiovascular system—migraine	0.000378	0.00691	CbGeAlD
Imatinib—NQO2—head—migraine	0.000369	0.00674	CbGeAlD
Imatinib—PDGFRA—head—migraine	0.000368	0.00672	CbGeAlD
Imatinib—PIP4K2C—brain—migraine	0.000364	0.00665	CbGeAlD
Imatinib—CA2—trigeminal ganglion—migraine	0.000356	0.00651	CbGeAlD
Imatinib—NQO2—nervous system—migraine	0.00035	0.00639	CbGeAlD
Imatinib—PDGFRA—nervous system—migraine	0.000349	0.00637	CbGeAlD
Imatinib—CA3—brain—migraine	0.000347	0.00635	CbGeAlD
Imatinib—CA12—head—migraine	0.00034	0.0062	CbGeAlD
Imatinib—NQO2—central nervous system—migraine	0.000337	0.00615	CbGeAlD
Imatinib—PDGFRA—central nervous system—migraine	0.000336	0.00613	CbGeAlD
Imatinib—ABCG2—trigeminal ganglion—migraine	0.00033	0.00603	CbGeAlD
Imatinib—NQO2—cerebellum—migraine	0.000329	0.00601	CbGeAlD
Imatinib—PDGFRA—cerebellum—migraine	0.000328	0.00599	CbGeAlD
Imatinib—CSF1R—head—migraine	0.000324	0.00592	CbGeAlD
Imatinib—CA12—nervous system—migraine	0.000322	0.00588	CbGeAlD
Imatinib—CA14—brain—migraine	0.000316	0.00576	CbGeAlD
Imatinib—CA2—brainstem—migraine	0.000315	0.00576	CbGeAlD
Imatinib—CA12—central nervous system—migraine	0.00031	0.00566	CbGeAlD
Imatinib—CSF1R—nervous system—migraine	0.000307	0.00561	CbGeAlD
Imatinib—SLC47A1—head—migraine	0.000296	0.0054	CbGeAlD
Imatinib—CSF1R—central nervous system—migraine	0.000296	0.0054	CbGeAlD
Imatinib—KIT—head—migraine	0.000294	0.00537	CbGeAlD
Imatinib—CSF1R—cerebellum—migraine	0.000289	0.00528	CbGeAlD
Imatinib—PDGFRB—head—migraine	0.000287	0.00525	CbGeAlD
Imatinib—SLC47A1—nervous system—migraine	0.00028	0.00512	CbGeAlD
Imatinib—KIT—nervous system—migraine	0.000279	0.00509	CbGeAlD
Imatinib—PDGFRB—nervous system—migraine	0.000272	0.00497	CbGeAlD
Imatinib—SLC47A1—central nervous system—migraine	0.00027	0.00493	CbGeAlD
Imatinib—CA1—head—migraine	0.000269	0.00491	CbGeAlD
Imatinib—KIT—central nervous system—migraine	0.000268	0.0049	CbGeAlD
Imatinib—NQO2—brain—migraine	0.000267	0.00488	CbGeAlD
Imatinib—PDGFRA—brain—migraine	0.000267	0.00487	CbGeAlD
Imatinib—SLC47A1—cerebellum—migraine	0.000264	0.00482	CbGeAlD
Imatinib—ABCB1—blood vessel—migraine	0.000264	0.00481	CbGeAlD
Imatinib—KIT—cerebellum—migraine	0.000262	0.00479	CbGeAlD
Imatinib—PDGFRB—central nervous system—migraine	0.000262	0.00479	CbGeAlD
Imatinib—CA2—cardiovascular system—migraine	0.000257	0.0047	CbGeAlD
Imatinib—PDGFRB—cerebellum—migraine	0.000256	0.00468	CbGeAlD
Imatinib—ABL1—head—migraine	0.000256	0.00468	CbGeAlD
Imatinib—ORM1—nervous system—migraine	0.000255	0.00467	CbGeAlD
Imatinib—CA1—nervous system—migraine	0.000255	0.00466	CbGeAlD
Imatinib—SLC22A1—head—migraine	0.000247	0.00451	CbGeAlD
Imatinib—CA12—brain—migraine	0.000246	0.00449	CbGeAlD
Imatinib—ORM1—central nervous system—migraine	0.000246	0.00449	CbGeAlD
Imatinib—CA1—central nervous system—migraine	0.000246	0.00448	CbGeAlD
Imatinib—ABL1—nervous system—migraine	0.000243	0.00443	CbGeAlD
Imatinib—CSF1R—brain—migraine	0.000235	0.00429	CbGeAlD
Imatinib—SLC22A1—nervous system—migraine	0.000234	0.00427	CbGeAlD
Imatinib—ABL1—central nervous system—migraine	0.000234	0.00427	CbGeAlD
Imatinib—ABL1—cerebellum—migraine	0.000228	0.00417	CbGeAlD
Imatinib—SLC22A1—central nervous system—migraine	0.000225	0.00411	CbGeAlD
Imatinib—CYP2C9—cardiovascular system—migraine	0.000218	0.00398	CbGeAlD
Imatinib—SLC47A1—brain—migraine	0.000214	0.00392	CbGeAlD
Imatinib—KIT—brain—migraine	0.000213	0.00389	CbGeAlD
Imatinib—PDGFRB—brain—migraine	0.000208	0.0038	CbGeAlD
Imatinib—CYP2D6—brainstem—migraine	0.0002	0.00366	CbGeAlD
Imatinib—PTGS1—cardiovascular system—migraine	0.000199	0.00363	CbGeAlD
Imatinib—CA1—brain—migraine	0.000195	0.00356	CbGeAlD
Imatinib—ABL1—brain—migraine	0.000186	0.00339	CbGeAlD
Imatinib—SLC22A1—brain—migraine	0.000179	0.00327	CbGeAlD
Imatinib—CA2—head—migraine	0.000174	0.00318	CbGeAlD
Imatinib—ALB—brain—migraine	0.000171	0.00313	CbGeAlD
Imatinib—CA2—nervous system—migraine	0.000165	0.00302	CbGeAlD
Imatinib—ABCB1—trigeminal ganglion—migraine	0.000163	0.00297	CbGeAlD
Imatinib—CA2—central nervous system—migraine	0.000159	0.00291	CbGeAlD
Imatinib—CA2—cerebellum—migraine	0.000156	0.00284	CbGeAlD
Imatinib—ABCG2—cerebellum—migraine	0.000144	0.00263	CbGeAlD
Imatinib—PTGS1—head—migraine	0.000135	0.00246	CbGeAlD
Imatinib—PTGS1—nervous system—migraine	0.000128	0.00233	CbGeAlD
Imatinib—CA2—brain—migraine	0.000126	0.00231	CbGeAlD
Imatinib—Dry mouth—Valproic Acid—migraine	0.000124	0.000666	CcSEcCtD
Imatinib—Erythema—Gabapentin—migraine	0.000124	0.000663	CcSEcCtD
Imatinib—Malnutrition—Gabapentin—migraine	0.000124	0.000663	CcSEcCtD
Imatinib—Dizziness—Propranolol—migraine	0.000123	0.000662	CcSEcCtD
Imatinib—Asthenia—Verapamil—migraine	0.000123	0.000661	CcSEcCtD
Imatinib—PTGS1—central nervous system—migraine	0.000123	0.00224	CbGeAlD
Imatinib—Confusional state—Valproic Acid—migraine	0.000123	0.000659	CcSEcCtD
Imatinib—Flatulence—Gabapentin—migraine	0.000122	0.000654	CcSEcCtD
Imatinib—Oedema—Valproic Acid—migraine	0.000122	0.000653	CcSEcCtD
Imatinib—Anaphylactic shock—Valproic Acid—migraine	0.000122	0.000653	CcSEcCtD
Imatinib—Pruritus—Verapamil—migraine	0.000121	0.000652	CcSEcCtD
Imatinib—Angioedema—Timolol—migraine	0.000121	0.000651	CcSEcCtD
Imatinib—Dysgeusia—Gabapentin—migraine	0.000121	0.00065	CcSEcCtD
Imatinib—Infection—Valproic Acid—migraine	0.000121	0.000649	CcSEcCtD
Imatinib—Haemoglobin—Topiramate—migraine	0.00012	0.000644	CcSEcCtD
Imatinib—Rhinitis—Topiramate—migraine	0.00012	0.000643	CcSEcCtD
Imatinib—Back pain—Gabapentin—migraine	0.00012	0.000642	CcSEcCtD
Imatinib—Haemorrhage—Topiramate—migraine	0.000119	0.000641	CcSEcCtD
Imatinib—Hepatitis—Topiramate—migraine	0.000119	0.000641	CcSEcCtD
Imatinib—Nervous system disorder—Valproic Acid—migraine	0.000119	0.000641	CcSEcCtD
Imatinib—Vertigo—Timolol—migraine	0.000119	0.00064	CcSEcCtD
Imatinib—Thrombocytopenia—Valproic Acid—migraine	0.000119	0.00064	CcSEcCtD
Imatinib—Syncope—Timolol—migraine	0.000119	0.000639	CcSEcCtD
Imatinib—Hypoaesthesia—Topiramate—migraine	0.000119	0.000638	CcSEcCtD
Imatinib—Muscle spasms—Gabapentin—migraine	0.000119	0.000638	CcSEcCtD
Imatinib—Tachycardia—Valproic Acid—migraine	0.000119	0.000638	CcSEcCtD
Imatinib—Vomiting—Propranolol—migraine	0.000119	0.000637	CcSEcCtD
Imatinib—Pharyngitis—Topiramate—migraine	0.000119	0.000636	CcSEcCtD
Imatinib—Skin disorder—Valproic Acid—migraine	0.000118	0.000634	CcSEcCtD
Imatinib—Urinary tract disorder—Topiramate—migraine	0.000118	0.000633	CcSEcCtD
Imatinib—Oedema peripheral—Topiramate—migraine	0.000118	0.000632	CcSEcCtD
Imatinib—Hyperhidrosis—Valproic Acid—migraine	0.000118	0.000631	CcSEcCtD
Imatinib—Rash—Propranolol—migraine	0.000118	0.000631	CcSEcCtD
Imatinib—ABCB1—cardiovascular system—migraine	0.000118	0.00215	CbGeAlD
Imatinib—Dermatitis—Propranolol—migraine	0.000118	0.000631	CcSEcCtD
Imatinib—Diarrhoea—Verapamil—migraine	0.000117	0.00063	CcSEcCtD
Imatinib—Connective tissue disorder—Topiramate—migraine	0.000117	0.00063	CcSEcCtD
Imatinib—Palpitations—Timolol—migraine	0.000117	0.00063	CcSEcCtD
Imatinib—Urethral disorder—Topiramate—migraine	0.000117	0.000629	CcSEcCtD
Imatinib—ABCG2—brain—migraine	0.000117	0.00214	CbGeAlD
Imatinib—Loss of consciousness—Timolol—migraine	0.000117	0.000626	CcSEcCtD
Imatinib—Vision blurred—Gabapentin—migraine	0.000116	0.000625	CcSEcCtD
Imatinib—Anorexia—Valproic Acid—migraine	0.000116	0.000623	CcSEcCtD
Imatinib—Cough—Timolol—migraine	0.000116	0.000622	CcSEcCtD
Imatinib—Tremor—Gabapentin—migraine	0.000116	0.000622	CcSEcCtD
Imatinib—Ill-defined disorder—Gabapentin—migraine	0.000115	0.000616	CcSEcCtD
Imatinib—Hypertension—Timolol—migraine	0.000115	0.000615	CcSEcCtD
Imatinib—Anaemia—Gabapentin—migraine	0.000114	0.000613	CcSEcCtD
Imatinib—Hypotension—Valproic Acid—migraine	0.000114	0.00061	CcSEcCtD
Imatinib—Dizziness—Verapamil—migraine	0.000113	0.000609	CcSEcCtD
Imatinib—Myalgia—Timolol—migraine	0.000113	0.000607	CcSEcCtD
Imatinib—Chest pain—Timolol—migraine	0.000113	0.000607	CcSEcCtD
Imatinib—Arthralgia—Timolol—migraine	0.000113	0.000607	CcSEcCtD
Imatinib—Erythema multiforme—Topiramate—migraine	0.000113	0.000606	CcSEcCtD
Imatinib—Angioedema—Gabapentin—migraine	0.000113	0.000606	CcSEcCtD
Imatinib—Anxiety—Timolol—migraine	0.000113	0.000604	CcSEcCtD
Imatinib—Unspecified disorder of skin and subcutaneous tissue—Timolol—migraine	0.000112	0.000602	CcSEcCtD
Imatinib—Discomfort—Timolol—migraine	0.000112	0.000599	CcSEcCtD
Imatinib—Eye disorder—Topiramate—migraine	0.000112	0.000599	CcSEcCtD
Imatinib—Malaise—Gabapentin—migraine	0.000111	0.000598	CcSEcCtD
Imatinib—Tinnitus—Topiramate—migraine	0.000111	0.000598	CcSEcCtD
Imatinib—Vertigo—Gabapentin—migraine	0.000111	0.000596	CcSEcCtD
Imatinib—Musculoskeletal discomfort—Valproic Acid—migraine	0.000111	0.000595	CcSEcCtD
Imatinib—Cardiac disorder—Topiramate—migraine	0.000111	0.000595	CcSEcCtD
Imatinib—Flushing—Topiramate—migraine	0.000111	0.000595	CcSEcCtD
Imatinib—Syncope—Gabapentin—migraine	0.000111	0.000595	CcSEcCtD
Imatinib—Nausea—Propranolol—migraine	0.000111	0.000595	CcSEcCtD
Imatinib—CYP2D6—head—migraine	0.000111	0.00202	CbGeAlD
Imatinib—Leukopenia—Gabapentin—migraine	0.000111	0.000594	CcSEcCtD
Imatinib—Dry mouth—Timolol—migraine	0.000111	0.000593	CcSEcCtD
Imatinib—Insomnia—Valproic Acid—migraine	0.00011	0.000591	CcSEcCtD
Imatinib—Paraesthesia—Valproic Acid—migraine	0.000109	0.000587	CcSEcCtD
Imatinib—Palpitations—Gabapentin—migraine	0.000109	0.000586	CcSEcCtD
Imatinib—Confusional state—Timolol—migraine	0.000109	0.000586	CcSEcCtD
Imatinib—Vomiting—Verapamil—migraine	0.000109	0.000586	CcSEcCtD
Imatinib—Loss of consciousness—Gabapentin—migraine	0.000109	0.000583	CcSEcCtD
Imatinib—Dyspnoea—Valproic Acid—migraine	0.000108	0.000582	CcSEcCtD
Imatinib—Angiopathy—Topiramate—migraine	0.000108	0.000582	CcSEcCtD
Imatinib—Anaphylactic shock—Timolol—migraine	0.000108	0.000581	CcSEcCtD
Imatinib—Oedema—Timolol—migraine	0.000108	0.000581	CcSEcCtD
Imatinib—Rash—Verapamil—migraine	0.000108	0.000581	CcSEcCtD
Imatinib—Somnolence—Valproic Acid—migraine	0.000108	0.000581	CcSEcCtD
Imatinib—Dermatitis—Verapamil—migraine	0.000108	0.00058	CcSEcCtD
Imatinib—Immune system disorder—Topiramate—migraine	0.000108	0.000579	CcSEcCtD
Imatinib—Cough—Gabapentin—migraine	0.000108	0.000579	CcSEcCtD
Imatinib—Mediastinal disorder—Topiramate—migraine	0.000108	0.000578	CcSEcCtD
Imatinib—Infection—Timolol—migraine	0.000108	0.000578	CcSEcCtD
Imatinib—Headache—Verapamil—migraine	0.000108	0.000577	CcSEcCtD
Imatinib—Chills—Topiramate—migraine	0.000107	0.000575	CcSEcCtD
Imatinib—Dyspepsia—Valproic Acid—migraine	0.000107	0.000575	CcSEcCtD
Imatinib—Convulsion—Gabapentin—migraine	0.000107	0.000575	CcSEcCtD
Imatinib—Hypertension—Gabapentin—migraine	0.000107	0.000573	CcSEcCtD
Imatinib—CYP3A4—nervous system—migraine	0.000107	0.00195	CbGeAlD
Imatinib—Shock—Timolol—migraine	0.000107	0.000572	CcSEcCtD
Imatinib—Nervous system disorder—Timolol—migraine	0.000106	0.00057	CcSEcCtD
Imatinib—Decreased appetite—Valproic Acid—migraine	0.000106	0.000568	CcSEcCtD
Imatinib—Alopecia—Topiramate—migraine	0.000106	0.000567	CcSEcCtD
Imatinib—Myalgia—Gabapentin—migraine	0.000105	0.000565	CcSEcCtD
Imatinib—Chest pain—Gabapentin—migraine	0.000105	0.000565	CcSEcCtD
Imatinib—Arthralgia—Gabapentin—migraine	0.000105	0.000565	CcSEcCtD
Imatinib—Skin disorder—Timolol—migraine	0.000105	0.000565	CcSEcCtD
Imatinib—Gastrointestinal disorder—Valproic Acid—migraine	0.000105	0.000564	CcSEcCtD
Imatinib—CYP2D6—nervous system—migraine	0.000105	0.00192	CbGeAlD
Imatinib—Fatigue—Valproic Acid—migraine	0.000105	0.000563	CcSEcCtD
Imatinib—Anxiety—Gabapentin—migraine	0.000105	0.000563	CcSEcCtD
Imatinib—Hyperhidrosis—Timolol—migraine	0.000105	0.000562	CcSEcCtD
Imatinib—Mental disorder—Topiramate—migraine	0.000105	0.000562	CcSEcCtD
Imatinib—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—migraine	0.000104	0.000561	CcSEcCtD
Imatinib—Constipation—Valproic Acid—migraine	0.000104	0.000559	CcSEcCtD
Imatinib—Pain—Valproic Acid—migraine	0.000104	0.000559	CcSEcCtD
Imatinib—Malnutrition—Topiramate—migraine	0.000104	0.000558	CcSEcCtD
Imatinib—Erythema—Topiramate—migraine	0.000104	0.000558	CcSEcCtD
Imatinib—Discomfort—Gabapentin—migraine	0.000104	0.000558	CcSEcCtD
Imatinib—Anorexia—Timolol—migraine	0.000103	0.000554	CcSEcCtD
Imatinib—Dry mouth—Gabapentin—migraine	0.000103	0.000552	CcSEcCtD
Imatinib—CYP3A4—central nervous system—migraine	0.000103	0.00188	CbGeAlD
Imatinib—Flatulence—Topiramate—migraine	0.000102	0.00055	CcSEcCtD
Imatinib—Nausea—Verapamil—migraine	0.000102	0.000547	CcSEcCtD
Imatinib—Dysgeusia—Topiramate—migraine	0.000102	0.000547	CcSEcCtD
Imatinib—Confusional state—Gabapentin—migraine	0.000102	0.000546	CcSEcCtD
Imatinib—Hypotension—Timolol—migraine	0.000101	0.000543	CcSEcCtD
Imatinib—CYP2D6—central nervous system—migraine	0.000101	0.00185	CbGeAlD
Imatinib—Anaphylactic shock—Gabapentin—migraine	0.000101	0.000541	CcSEcCtD
Imatinib—Oedema—Gabapentin—migraine	0.000101	0.000541	CcSEcCtD
Imatinib—Back pain—Topiramate—migraine	0.000101	0.00054	CcSEcCtD
Imatinib—Feeling abnormal—Valproic Acid—migraine	0.0001	0.000538	CcSEcCtD
Imatinib—Infection—Gabapentin—migraine	0.0001	0.000538	CcSEcCtD
Imatinib—Muscle spasms—Topiramate—migraine	0.0001	0.000537	CcSEcCtD
Imatinib—Gastrointestinal pain—Valproic Acid—migraine	9.95e-05	0.000534	CcSEcCtD
Imatinib—Shock—Gabapentin—migraine	9.92e-05	0.000533	CcSEcCtD
Imatinib—Nervous system disorder—Gabapentin—migraine	9.89e-05	0.000531	CcSEcCtD
Imatinib—Thrombocytopenia—Gabapentin—migraine	9.88e-05	0.00053	CcSEcCtD
Imatinib—CYP2D6—cerebellum—migraine	9.87e-05	0.0018	CbGeAlD
Imatinib—Musculoskeletal discomfort—Timolol—migraine	9.87e-05	0.00053	CcSEcCtD
Imatinib—Tachycardia—Gabapentin—migraine	9.84e-05	0.000528	CcSEcCtD
Imatinib—Vision blurred—Topiramate—migraine	9.8e-05	0.000526	CcSEcCtD
Imatinib—Skin disorder—Gabapentin—migraine	9.8e-05	0.000526	CcSEcCtD
Imatinib—Insomnia—Timolol—migraine	9.8e-05	0.000526	CcSEcCtD
Imatinib—PTGS1—brain—migraine	9.76e-05	0.00178	CbGeAlD
Imatinib—Hyperhidrosis—Gabapentin—migraine	9.75e-05	0.000523	CcSEcCtD
Imatinib—Tremor—Topiramate—migraine	9.74e-05	0.000523	CcSEcCtD
Imatinib—Paraesthesia—Timolol—migraine	9.73e-05	0.000522	CcSEcCtD
Imatinib—Urticaria—Valproic Acid—migraine	9.67e-05	0.000519	CcSEcCtD
Imatinib—Dyspnoea—Timolol—migraine	9.66e-05	0.000518	CcSEcCtD
Imatinib—Ill-defined disorder—Topiramate—migraine	9.65e-05	0.000518	CcSEcCtD
Imatinib—Somnolence—Timolol—migraine	9.63e-05	0.000517	CcSEcCtD
Imatinib—Abdominal pain—Valproic Acid—migraine	9.62e-05	0.000516	CcSEcCtD
Imatinib—Body temperature increased—Valproic Acid—migraine	9.62e-05	0.000516	CcSEcCtD
Imatinib—Anorexia—Gabapentin—migraine	9.61e-05	0.000516	CcSEcCtD
Imatinib—Anaemia—Topiramate—migraine	9.61e-05	0.000516	CcSEcCtD
Imatinib—Dyspepsia—Timolol—migraine	9.53e-05	0.000512	CcSEcCtD
Imatinib—Hypotension—Gabapentin—migraine	9.43e-05	0.000506	CcSEcCtD
Imatinib—Decreased appetite—Timolol—migraine	9.42e-05	0.000505	CcSEcCtD
Imatinib—Malaise—Topiramate—migraine	9.38e-05	0.000503	CcSEcCtD
Imatinib—Gastrointestinal disorder—Timolol—migraine	9.35e-05	0.000502	CcSEcCtD
Imatinib—Vertigo—Topiramate—migraine	9.34e-05	0.000502	CcSEcCtD
Imatinib—Fatigue—Timolol—migraine	9.34e-05	0.000501	CcSEcCtD
Imatinib—Syncope—Topiramate—migraine	9.32e-05	0.000501	CcSEcCtD
Imatinib—Leukopenia—Topiramate—migraine	9.31e-05	0.0005	CcSEcCtD
Imatinib—Pain—Timolol—migraine	9.26e-05	0.000497	CcSEcCtD
Imatinib—Musculoskeletal discomfort—Gabapentin—migraine	9.19e-05	0.000493	CcSEcCtD
Imatinib—Palpitations—Topiramate—migraine	9.19e-05	0.000493	CcSEcCtD
Imatinib—Loss of consciousness—Topiramate—migraine	9.14e-05	0.000491	CcSEcCtD
Imatinib—Insomnia—Gabapentin—migraine	9.12e-05	0.00049	CcSEcCtD
Imatinib—Cough—Topiramate—migraine	9.07e-05	0.000487	CcSEcCtD
Imatinib—Paraesthesia—Gabapentin—migraine	9.06e-05	0.000486	CcSEcCtD
Imatinib—Convulsion—Topiramate—migraine	9.01e-05	0.000484	CcSEcCtD
Imatinib—Dyspnoea—Gabapentin—migraine	8.99e-05	0.000483	CcSEcCtD
Imatinib—Hypertension—Topiramate—migraine	8.98e-05	0.000482	CcSEcCtD
Imatinib—Somnolence—Gabapentin—migraine	8.97e-05	0.000481	CcSEcCtD
Imatinib—Hypersensitivity—Valproic Acid—migraine	8.96e-05	0.000481	CcSEcCtD
Imatinib—Feeling abnormal—Timolol—migraine	8.93e-05	0.000479	CcSEcCtD
Imatinib—Dyspepsia—Gabapentin—migraine	8.88e-05	0.000477	CcSEcCtD
Imatinib—Gastrointestinal pain—Timolol—migraine	8.86e-05	0.000475	CcSEcCtD
Imatinib—Myalgia—Topiramate—migraine	8.85e-05	0.000475	CcSEcCtD
Imatinib—Arthralgia—Topiramate—migraine	8.85e-05	0.000475	CcSEcCtD
Imatinib—Chest pain—Topiramate—migraine	8.85e-05	0.000475	CcSEcCtD
Imatinib—Anxiety—Topiramate—migraine	8.82e-05	0.000474	CcSEcCtD
Imatinib—Unspecified disorder of skin and subcutaneous tissue—Topiramate—migraine	8.79e-05	0.000472	CcSEcCtD
Imatinib—Decreased appetite—Gabapentin—migraine	8.77e-05	0.000471	CcSEcCtD
Imatinib—Discomfort—Topiramate—migraine	8.75e-05	0.00047	CcSEcCtD
Imatinib—Asthenia—Valproic Acid—migraine	8.73e-05	0.000469	CcSEcCtD
Imatinib—Gastrointestinal disorder—Gabapentin—migraine	8.71e-05	0.000467	CcSEcCtD
Imatinib—Fatigue—Gabapentin—migraine	8.7e-05	0.000467	CcSEcCtD
Imatinib—Dry mouth—Topiramate—migraine	8.66e-05	0.000465	CcSEcCtD
Imatinib—Constipation—Gabapentin—migraine	8.63e-05	0.000463	CcSEcCtD
Imatinib—Pain—Gabapentin—migraine	8.63e-05	0.000463	CcSEcCtD
Imatinib—Pruritus—Valproic Acid—migraine	8.61e-05	0.000462	CcSEcCtD
Imatinib—Urticaria—Timolol—migraine	8.6e-05	0.000462	CcSEcCtD
Imatinib—Abdominal pain—Timolol—migraine	8.56e-05	0.00046	CcSEcCtD
Imatinib—Body temperature increased—Timolol—migraine	8.56e-05	0.00046	CcSEcCtD
Imatinib—Confusional state—Topiramate—migraine	8.56e-05	0.000459	CcSEcCtD
Imatinib—Oedema—Topiramate—migraine	8.49e-05	0.000456	CcSEcCtD
Imatinib—Infection—Topiramate—migraine	8.43e-05	0.000453	CcSEcCtD
Imatinib—Shock—Topiramate—migraine	8.35e-05	0.000448	CcSEcCtD
Imatinib—Diarrhoea—Valproic Acid—migraine	8.33e-05	0.000447	CcSEcCtD
Imatinib—Nervous system disorder—Topiramate—migraine	8.32e-05	0.000447	CcSEcCtD
Imatinib—Feeling abnormal—Gabapentin—migraine	8.31e-05	0.000446	CcSEcCtD
Imatinib—Thrombocytopenia—Topiramate—migraine	8.31e-05	0.000446	CcSEcCtD
Imatinib—Tachycardia—Topiramate—migraine	8.28e-05	0.000445	CcSEcCtD
Imatinib—Gastrointestinal pain—Gabapentin—migraine	8.25e-05	0.000443	CcSEcCtD
Imatinib—Skin disorder—Topiramate—migraine	8.24e-05	0.000443	CcSEcCtD
Imatinib—Hyperhidrosis—Topiramate—migraine	8.2e-05	0.00044	CcSEcCtD
Imatinib—Anorexia—Topiramate—migraine	8.09e-05	0.000434	CcSEcCtD
Imatinib—Dizziness—Valproic Acid—migraine	8.05e-05	0.000432	CcSEcCtD
Imatinib—CYP2D6—brain—migraine	8.02e-05	0.00146	CbGeAlD
Imatinib—Urticaria—Gabapentin—migraine	8.01e-05	0.00043	CcSEcCtD
Imatinib—Hypersensitivity—Timolol—migraine	7.98e-05	0.000428	CcSEcCtD
Imatinib—Body temperature increased—Gabapentin—migraine	7.97e-05	0.000428	CcSEcCtD
Imatinib—Abdominal pain—Gabapentin—migraine	7.97e-05	0.000428	CcSEcCtD
Imatinib—ABCB1—head—migraine	7.96e-05	0.00145	CbGeAlD
Imatinib—NTRK1—MAPK Signaling Pathway—TGFBR2—migraine	7.94e-05	0.00477	CbGpPWpGaD
Imatinib—Hypotension—Topiramate—migraine	7.93e-05	0.000426	CcSEcCtD
Imatinib—LCK—IL-2 Signaling Pathway—FOS—migraine	7.85e-05	0.00471	CbGpPWpGaD
Imatinib—Asthenia—Timolol—migraine	7.77e-05	0.000417	CcSEcCtD
Imatinib—Vomiting—Valproic Acid—migraine	7.74e-05	0.000415	CcSEcCtD
Imatinib—Musculoskeletal discomfort—Topiramate—migraine	7.73e-05	0.000415	CcSEcCtD
Imatinib—Insomnia—Topiramate—migraine	7.68e-05	0.000412	CcSEcCtD
Imatinib—Rash—Valproic Acid—migraine	7.67e-05	0.000412	CcSEcCtD
Imatinib—Dermatitis—Valproic Acid—migraine	7.66e-05	0.000411	CcSEcCtD
Imatinib—Pruritus—Timolol—migraine	7.66e-05	0.000411	CcSEcCtD
Imatinib—NTRK1—MAPK Signaling Pathway—BDNF—migraine	7.64e-05	0.00459	CbGpPWpGaD
Imatinib—Headache—Valproic Acid—migraine	7.62e-05	0.000409	CcSEcCtD
Imatinib—Paraesthesia—Topiramate—migraine	7.62e-05	0.000409	CcSEcCtD
Imatinib—SLC22A1—Transmission across Chemical Synapses—CACNA1A—migraine	7.6e-05	0.00456	CbGpPWpGaD
Imatinib—Dyspnoea—Topiramate—migraine	7.57e-05	0.000406	CcSEcCtD
Imatinib—ABCB1—nervous system—migraine	7.55e-05	0.00138	CbGeAlD
Imatinib—Somnolence—Topiramate—migraine	7.54e-05	0.000405	CcSEcCtD
Imatinib—Dyspepsia—Topiramate—migraine	7.47e-05	0.000401	CcSEcCtD
Imatinib—Hypersensitivity—Gabapentin—migraine	7.43e-05	0.000399	CcSEcCtD
Imatinib—Diarrhoea—Timolol—migraine	7.41e-05	0.000398	CcSEcCtD
Imatinib—PTGS1—Overview of nanoparticle effects—TNF—migraine	7.41e-05	0.00445	CbGpPWpGaD
Imatinib—Decreased appetite—Topiramate—migraine	7.38e-05	0.000396	CcSEcCtD
Imatinib—Gastrointestinal disorder—Topiramate—migraine	7.33e-05	0.000393	CcSEcCtD
Imatinib—Fatigue—Topiramate—migraine	7.32e-05	0.000393	CcSEcCtD
Imatinib—ABCB1—central nervous system—migraine	7.27e-05	0.00133	CbGeAlD
Imatinib—PDGFRB—Signaling by ERBB4—PGR—migraine	7.27e-05	0.00436	CbGpPWpGaD
Imatinib—Pain—Topiramate—migraine	7.26e-05	0.00039	CcSEcCtD
Imatinib—Constipation—Topiramate—migraine	7.26e-05	0.00039	CcSEcCtD
Imatinib—Asthenia—Gabapentin—migraine	7.24e-05	0.000389	CcSEcCtD
Imatinib—Nausea—Valproic Acid—migraine	7.23e-05	0.000388	CcSEcCtD
Imatinib—ABL1—Regulation of Telomerase—ESR1—migraine	7.2e-05	0.00432	CbGpPWpGaD
Imatinib—Dizziness—Timolol—migraine	7.16e-05	0.000385	CcSEcCtD
Imatinib—Pruritus—Gabapentin—migraine	7.14e-05	0.000383	CcSEcCtD
Imatinib—ABCB1—cerebellum—migraine	7.1e-05	0.0013	CbGeAlD
Imatinib—Feeling abnormal—Topiramate—migraine	6.99e-05	0.000375	CcSEcCtD
Imatinib—Gastrointestinal pain—Topiramate—migraine	6.94e-05	0.000373	CcSEcCtD
Imatinib—ABL1—Developmental Biology—SCN1A—migraine	6.93e-05	0.00416	CbGpPWpGaD
Imatinib—Diarrhoea—Gabapentin—migraine	6.9e-05	0.00037	CcSEcCtD
Imatinib—NTRK1—Integrated Pancreatic Cancer Pathway—BDNF—migraine	6.9e-05	0.00414	CbGpPWpGaD
Imatinib—Vomiting—Timolol—migraine	6.89e-05	0.00037	CcSEcCtD
Imatinib—Rash—Timolol—migraine	6.83e-05	0.000367	CcSEcCtD
Imatinib—Dermatitis—Timolol—migraine	6.82e-05	0.000366	CcSEcCtD
Imatinib—Headache—Timolol—migraine	6.79e-05	0.000364	CcSEcCtD
Imatinib—Urticaria—Topiramate—migraine	6.74e-05	0.000362	CcSEcCtD
Imatinib—Abdominal pain—Topiramate—migraine	6.71e-05	0.00036	CcSEcCtD
Imatinib—Body temperature increased—Topiramate—migraine	6.71e-05	0.00036	CcSEcCtD
Imatinib—Dizziness—Gabapentin—migraine	6.67e-05	0.000358	CcSEcCtD
Imatinib—ABL1—Regulation of Telomerase—FOS—migraine	6.48e-05	0.00389	CbGpPWpGaD
Imatinib—Nausea—Timolol—migraine	6.43e-05	0.000345	CcSEcCtD
Imatinib—LCK—IL2-mediated signaling events—FOS—migraine	6.42e-05	0.00385	CbGpPWpGaD
Imatinib—Vomiting—Gabapentin—migraine	6.41e-05	0.000344	CcSEcCtD
Imatinib—Rash—Gabapentin—migraine	6.36e-05	0.000341	CcSEcCtD
Imatinib—Dermatitis—Gabapentin—migraine	6.35e-05	0.000341	CcSEcCtD
Imatinib—Headache—Gabapentin—migraine	6.32e-05	0.000339	CcSEcCtD
Imatinib—Hypersensitivity—Topiramate—migraine	6.25e-05	0.000336	CcSEcCtD
Imatinib—SLC22A2—Neuronal System—CACNA1A—migraine	6.25e-05	0.00375	CbGpPWpGaD
Imatinib—ABCG2—Transmembrane transport of small molecules—TRPM8—migraine	6.19e-05	0.00372	CbGpPWpGaD
Imatinib—SLC22A2—Transmembrane transport of small molecules—TRPM8—migraine	6.13e-05	0.00368	CbGpPWpGaD
Imatinib—Asthenia—Topiramate—migraine	6.09e-05	0.000327	CcSEcCtD
Imatinib—Pruritus—Topiramate—migraine	6e-05	0.000322	CcSEcCtD
Imatinib—Nausea—Gabapentin—migraine	5.99e-05	0.000322	CcSEcCtD
Imatinib—LCK—IL12-mediated signaling events—FOS—migraine	5.9e-05	0.00354	CbGpPWpGaD
Imatinib—ABL1—Developmental Biology—SCN2A—migraine	5.89e-05	0.00354	CbGpPWpGaD
Imatinib—NTRK1—BDNF signaling pathway—FOS—migraine	5.84e-05	0.00351	CbGpPWpGaD
Imatinib—LCK—Signaling by ERBB4—PGR—migraine	5.83e-05	0.0035	CbGpPWpGaD
Imatinib—SLC22A1—Neuronal System—CACNA1A—migraine	5.82e-05	0.00349	CbGpPWpGaD
Imatinib—Diarrhoea—Topiramate—migraine	5.81e-05	0.000312	CcSEcCtD
Imatinib—CA14—Metabolism—CACNA1A—migraine	5.79e-05	0.00348	CbGpPWpGaD
Imatinib—ABCB1—brain—migraine	5.77e-05	0.00105	CbGeAlD
Imatinib—SLC22A1—Transmembrane transport of small molecules—TRPM8—migraine	5.71e-05	0.00343	CbGpPWpGaD
Imatinib—CA6—Metabolism—CACNA1A—migraine	5.64e-05	0.00339	CbGpPWpGaD
Imatinib—Dizziness—Topiramate—migraine	5.61e-05	0.000301	CcSEcCtD
Imatinib—Vomiting—Topiramate—migraine	5.4e-05	0.00029	CcSEcCtD
Imatinib—ABL1—Developmental Biology—MEF2D—migraine	5.39e-05	0.00323	CbGpPWpGaD
Imatinib—Rash—Topiramate—migraine	5.35e-05	0.000287	CcSEcCtD
Imatinib—Dermatitis—Topiramate—migraine	5.35e-05	0.000287	CcSEcCtD
Imatinib—Headache—Topiramate—migraine	5.32e-05	0.000285	CcSEcCtD
Imatinib—ABCG2—HIF-1-alpha transcription factor network—FOS—migraine	5.3e-05	0.00318	CbGpPWpGaD
Imatinib—CA7—Metabolism—CACNA1A—migraine	5.27e-05	0.00316	CbGpPWpGaD
Imatinib—ABL1—Integrated Breast Cancer Pathway—TGFBR2—migraine	5.27e-05	0.00316	CbGpPWpGaD
Imatinib—NTRK1—Integrated Pancreatic Cancer Pathway—ESR1—migraine	5.17e-05	0.0031	CbGpPWpGaD
Imatinib—NTRK1—MAPK Signaling Pathway—FOS—migraine	5.17e-05	0.0031	CbGpPWpGaD
Imatinib—PTGS1—Selenium Micronutrient Network—MTHFR—migraine	5.05e-05	0.00303	CbGpPWpGaD
Imatinib—Nausea—Topiramate—migraine	5.04e-05	0.000271	CcSEcCtD
Imatinib—ALB—Vitamin B12 Metabolism—MTHFR—migraine	5.02e-05	0.00301	CbGpPWpGaD
Imatinib—PDGFRB—MAPK Signaling Pathway—TGFBR2—migraine	4.96e-05	0.00298	CbGpPWpGaD
Imatinib—CA12—Metabolism—CACNA1A—migraine	4.88e-05	0.00293	CbGpPWpGaD
Imatinib—PDGFRA—Integrated Pancreatic Cancer Pathway—BDNF—migraine	4.78e-05	0.00287	CbGpPWpGaD
Imatinib—PDGFRB—MAPK Signaling Pathway—BDNF—migraine	4.78e-05	0.00287	CbGpPWpGaD
Imatinib—ABCG2—Transmembrane transport of small molecules—ATP1A3—migraine	4.69e-05	0.00282	CbGpPWpGaD
Imatinib—ABCG2—Transmembrane transport of small molecules—ATP1A2—migraine	4.69e-05	0.00282	CbGpPWpGaD
Imatinib—SLC22A2—Transmembrane transport of small molecules—ATP1A3—migraine	4.64e-05	0.00279	CbGpPWpGaD
Imatinib—SLC22A2—Transmembrane transport of small molecules—ATP1A2—migraine	4.64e-05	0.00279	CbGpPWpGaD
Imatinib—KIT—Signaling by ERBB4—ESR1—migraine	4.55e-05	0.00273	CbGpPWpGaD
Imatinib—SLC22A1—Transmembrane transport of small molecules—ATP1A3—migraine	4.33e-05	0.0026	CbGpPWpGaD
Imatinib—SLC22A1—Transmembrane transport of small molecules—ATP1A2—migraine	4.33e-05	0.0026	CbGpPWpGaD
Imatinib—PDGFRA—Signaling by ERBB4—ESR1—migraine	4.31e-05	0.00259	CbGpPWpGaD
Imatinib—ABL1—Apoptosis-related network due to altered Notch3 in ovarian cancer—TNF—migraine	4.26e-05	0.00255	CbGpPWpGaD
Imatinib—ABL1—Integrated Pancreatic Cancer Pathway—BDNF—migraine	4.2e-05	0.00252	CbGpPWpGaD
Imatinib—PDGFRB—PDGFR-beta signaling pathway—FOS—migraine	4.09e-05	0.00245	CbGpPWpGaD
Imatinib—ALB—Folate Metabolism—MTHFR—migraine	4.08e-05	0.00245	CbGpPWpGaD
Imatinib—ABCG2—Transmembrane transport of small molecules—HTR3A—migraine	3.99e-05	0.0024	CbGpPWpGaD
Imatinib—ABL1—PDGFR-beta signaling pathway—FOS—migraine	3.98e-05	0.00239	CbGpPWpGaD
Imatinib—SLC22A2—Transmembrane transport of small molecules—HTR3A—migraine	3.95e-05	0.00237	CbGpPWpGaD
Imatinib—PDGFRB—Signaling by ERBB4—ESR1—migraine	3.88e-05	0.00233	CbGpPWpGaD
Imatinib—ALB—Transmembrane transport of small molecules—TRPM8—migraine	3.82e-05	0.00229	CbGpPWpGaD
Imatinib—ABL1—Integrated Breast Cancer Pathway—ESR1—migraine	3.8e-05	0.00228	CbGpPWpGaD
Imatinib—CA2—Metabolism—CACNA1A—migraine	3.73e-05	0.00224	CbGpPWpGaD
Imatinib—SLC22A1—Transmembrane transport of small molecules—HTR3A—migraine	3.68e-05	0.00221	CbGpPWpGaD
Imatinib—KIT—Fc epsilon receptor (FCERI) signaling—FOS—migraine	3.63e-05	0.00218	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—RAMP1—migraine	3.61e-05	0.00217	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—CALCRL—migraine	3.61e-05	0.00217	CbGpPWpGaD
Imatinib—PDGFRA—Integrated Pancreatic Cancer Pathway—ESR1—migraine	3.59e-05	0.00215	CbGpPWpGaD
Imatinib—CA1—Metabolism—CACNA1A—migraine	3.58e-05	0.00215	CbGpPWpGaD
Imatinib—PDGFRA—Allograft Rejection—TNF—migraine	3.52e-05	0.00211	CbGpPWpGaD
Imatinib—CA9—Cellular responses to stress—FOS—migraine	3.46e-05	0.00208	CbGpPWpGaD
Imatinib—PDGFRA—Fc epsilon receptor (FCERI) signaling—FOS—migraine	3.44e-05	0.00206	CbGpPWpGaD
Imatinib—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—migraine	3.39e-05	0.00203	CbGpPWpGaD
Imatinib—ABCB1—Transmembrane transport of small molecules—TRPM8—migraine	3.35e-05	0.00201	CbGpPWpGaD
Imatinib—LCK—PDGFR-beta signaling pathway—FOS—migraine	3.28e-05	0.00197	CbGpPWpGaD
Imatinib—ALB—Selenium Micronutrient Network—MTHFR—migraine	3.24e-05	0.00195	CbGpPWpGaD
Imatinib—ABL1—EGF/EGFR Signaling Pathway—FOS—migraine	3.24e-05	0.00194	CbGpPWpGaD
Imatinib—PDGFRB—MAPK Signaling Pathway—FOS—migraine	3.23e-05	0.00194	CbGpPWpGaD
Imatinib—ABL1—Integrated Pancreatic Cancer Pathway—ESR1—migraine	3.15e-05	0.00189	CbGpPWpGaD
Imatinib—CA9—Metabolism—CACNA1A—migraine	3.14e-05	0.00189	CbGpPWpGaD
Imatinib—LCK—Signaling by ERBB4—ESR1—migraine	3.11e-05	0.00187	CbGpPWpGaD
Imatinib—PDGFRB—Fc epsilon receptor (FCERI) signaling—FOS—migraine	3.1e-05	0.00186	CbGpPWpGaD
Imatinib—CA3—Metabolism—MTHFR—migraine	2.97e-05	0.00178	CbGpPWpGaD
Imatinib—ALB—Transmembrane transport of small molecules—ATP1A3—migraine	2.9e-05	0.00174	CbGpPWpGaD
Imatinib—ALB—Transmembrane transport of small molecules—ATP1A2—migraine	2.9e-05	0.00174	CbGpPWpGaD
Imatinib—ABCB1—HIF-1-alpha transcription factor network—FOS—migraine	2.86e-05	0.00172	CbGpPWpGaD
Imatinib—NTRK1—MAPK Signaling Pathway—TNF—migraine	2.78e-05	0.00167	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—RAMP1—migraine	2.64e-05	0.00159	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—CALCRL—migraine	2.64e-05	0.00159	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—HTR1D—migraine	2.62e-05	0.00157	CbGpPWpGaD
Imatinib—ABCB1—Transmembrane transport of small molecules—ATP1A3—migraine	2.54e-05	0.00152	CbGpPWpGaD
Imatinib—ABCB1—Transmembrane transport of small molecules—ATP1A2—migraine	2.54e-05	0.00152	CbGpPWpGaD
Imatinib—NTRK1—Integrated Pancreatic Cancer Pathway—TNF—migraine	2.51e-05	0.0015	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—RAMP1—migraine	2.5e-05	0.0015	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—CALCRL—migraine	2.5e-05	0.0015	CbGpPWpGaD
Imatinib—LCK—Fc epsilon receptor (FCERI) signaling—FOS—migraine	2.48e-05	0.00149	CbGpPWpGaD
Imatinib—ALB—Transmembrane transport of small molecules—HTR3A—migraine	2.46e-05	0.00148	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—HTR2B—migraine	2.44e-05	0.00146	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—CALCRL—migraine	2.26e-05	0.00135	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—RAMP1—migraine	2.26e-05	0.00135	CbGpPWpGaD
Imatinib—KIT—Disease—LRP1—migraine	2.25e-05	0.00135	CbGpPWpGaD
Imatinib—PTGS1—Selenium Micronutrient Network—TNF—migraine	2.17e-05	0.00131	CbGpPWpGaD
Imatinib—ALB—Vitamin B12 Metabolism—TNF—migraine	2.16e-05	0.0013	CbGpPWpGaD
Imatinib—ABCB1—Transmembrane transport of small molecules—HTR3A—migraine	2.16e-05	0.0013	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—LRP1—migraine	2.15e-05	0.00129	CbGpPWpGaD
Imatinib—PDGFRA—Disease—LRP1—migraine	2.13e-05	0.00128	CbGpPWpGaD
Imatinib—ABL2—Developmental Biology—TNF—migraine	2.02e-05	0.00121	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—HTR1D—migraine	1.92e-05	0.00115	CbGpPWpGaD
Imatinib—PDGFRB—Disease—LRP1—migraine	1.92e-05	0.00115	CbGpPWpGaD
Imatinib—CA14—Metabolism—MTHFR—migraine	1.92e-05	0.00115	CbGpPWpGaD
Imatinib—CA6—Metabolism—MTHFR—migraine	1.87e-05	0.00112	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—HTR1D—migraine	1.82e-05	0.00109	CbGpPWpGaD
Imatinib—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—migraine	1.81e-05	0.00109	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—CALCRL—migraine	1.81e-05	0.00109	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—RAMP1—migraine	1.81e-05	0.00109	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—HTR2B—migraine	1.79e-05	0.00107	CbGpPWpGaD
Imatinib—ALB—Folate Metabolism—TNF—migraine	1.76e-05	0.00106	CbGpPWpGaD
Imatinib—CA7—Metabolism—MTHFR—migraine	1.74e-05	0.00105	CbGpPWpGaD
Imatinib—PDGFRA—Integrated Pancreatic Cancer Pathway—TNF—migraine	1.74e-05	0.00104	CbGpPWpGaD
Imatinib—PDGFRB—MAPK Signaling Pathway—TNF—migraine	1.74e-05	0.00104	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—HTR2B—migraine	1.69e-05	0.00102	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—NOTCH4—migraine	1.65e-05	0.000989	CbGpPWpGaD
Imatinib—CYP1A2—Aryl Hydrocarbon Receptor—TNF—migraine	1.64e-05	0.000985	CbGpPWpGaD
Imatinib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—migraine	1.64e-05	0.000985	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—HTR1D—migraine	1.64e-05	0.000984	CbGpPWpGaD
Imatinib—CA12—Metabolism—MTHFR—migraine	1.61e-05	0.000969	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—CACNA1A—migraine	1.59e-05	0.000954	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—HTR1B—migraine	1.59e-05	0.000954	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—CACNA1A—migraine	1.58e-05	0.000946	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—LRP1—migraine	1.57e-05	0.000944	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—CACNA1A—migraine	1.57e-05	0.000944	CbGpPWpGaD
Imatinib—LCK—Disease—LRP1—migraine	1.54e-05	0.000923	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—HTR1A—migraine	1.53e-05	0.000918	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—CACNA1A—migraine	1.53e-05	0.000917	CbGpPWpGaD
Imatinib—ABL1—Integrated Pancreatic Cancer Pathway—TNF—migraine	1.53e-05	0.000916	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—HTR2B—migraine	1.52e-05	0.000915	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—PGR—migraine	1.51e-05	0.000904	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—NPS—migraine	1.51e-05	0.000904	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—TAC1—migraine	1.51e-05	0.000904	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—LRP1—migraine	1.49e-05	0.000894	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—HTR2C—migraine	1.48e-05	0.000887	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—CACNA1A—migraine	1.47e-05	0.00088	CbGpPWpGaD
Imatinib—KIT—Disease—CALCA—migraine	1.45e-05	0.000869	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—EDNRA—migraine	1.44e-05	0.000863	CbGpPWpGaD
Imatinib—KIT—Innate Immune System—FOS—migraine	1.41e-05	0.000847	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—NOTCH3—migraine	1.4e-05	0.000841	CbGpPWpGaD
Imatinib—ALB—Selenium Micronutrient Network—TNF—migraine	1.4e-05	0.000838	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—CALCA—migraine	1.38e-05	0.00083	CbGpPWpGaD
Imatinib—PDGFRA—Disease—CALCA—migraine	1.37e-05	0.000822	CbGpPWpGaD
Imatinib—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—migraine	1.36e-05	0.000815	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—LRP1—migraine	1.34e-05	0.000805	CbGpPWpGaD
Imatinib—PDGFRA—Innate Immune System—FOS—migraine	1.34e-05	0.000801	CbGpPWpGaD
Imatinib—ABCB1—Allograft Rejection—TNF—migraine	1.33e-05	0.000801	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—HTR1D—migraine	1.32e-05	0.000789	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—HTR7—migraine	1.29e-05	0.000777	CbGpPWpGaD
Imatinib—PDGFRB—Disease—CALCA—migraine	1.23e-05	0.000741	CbGpPWpGaD
Imatinib—CA2—Metabolism—MTHFR—migraine	1.23e-05	0.000741	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—HTR2B—migraine	1.22e-05	0.000734	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—NOTCH4—migraine	1.21e-05	0.000724	CbGpPWpGaD
Imatinib—PDGFRB—Innate Immune System—FOS—migraine	1.2e-05	0.000722	CbGpPWpGaD
Imatinib—CA1—Metabolism—MTHFR—migraine	1.18e-05	0.00071	CbGpPWpGaD
Imatinib—ABL1—Innate Immune System—FOS—migraine	1.17e-05	0.000704	CbGpPWpGaD
Imatinib—KIT—Disease—TGFBR2—migraine	1.17e-05	0.0007	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—HTR1B—migraine	1.16e-05	0.000699	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—NOTCH4—migraine	1.14e-05	0.000686	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—CACNA1A—migraine	1.14e-05	0.000684	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—HTR1A—migraine	1.12e-05	0.000673	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—TGFBR2—migraine	1.11e-05	0.000669	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—PGR—migraine	1.1e-05	0.000663	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—NPS—migraine	1.1e-05	0.000663	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—TAC1—migraine	1.1e-05	0.000663	CbGpPWpGaD
Imatinib—PDGFRA—Disease—TGFBR2—migraine	1.1e-05	0.000662	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—HTR1B—migraine	1.1e-05	0.000662	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—HTR2C—migraine	1.08e-05	0.00065	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—LRP1—migraine	1.08e-05	0.000646	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—HTR1A—migraine	1.06e-05	0.000637	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—EDNRA—migraine	1.05e-05	0.000632	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—TAC1—migraine	1.04e-05	0.000627	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—NPS—migraine	1.04e-05	0.000627	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—PGR—migraine	1.04e-05	0.000627	CbGpPWpGaD
Imatinib—CA9—Metabolism—MTHFR—migraine	1.04e-05	0.000624	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—NOTCH4—migraine	1.03e-05	0.000618	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—NOTCH3—migraine	1.03e-05	0.000616	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—HTR2C—migraine	1.02e-05	0.000615	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—CALCA—migraine	1.01e-05	0.000608	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—EDNRA—migraine	9.97e-06	0.000598	CbGpPWpGaD
Imatinib—PDGFRB—Disease—TGFBR2—migraine	9.94e-06	0.000597	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—HTR1B—migraine	9.93e-06	0.000596	CbGpPWpGaD
Imatinib—LCK—Disease—CALCA—migraine	9.9e-06	0.000595	CbGpPWpGaD
Imatinib—ALB—Metabolism—CACNA1A—migraine	9.81e-06	0.000589	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—NOTCH3—migraine	9.71e-06	0.000583	CbGpPWpGaD
Imatinib—LCK—Innate Immune System—FOS—migraine	9.65e-06	0.000579	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—CALCA—migraine	9.59e-06	0.000576	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—HTR1A—migraine	9.56e-06	0.000574	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—HTR7—migraine	9.48e-06	0.000569	CbGpPWpGaD
Imatinib—KIT—Disease—MTHFR—migraine	9.47e-06	0.000568	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—TAC1—migraine	9.41e-06	0.000565	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—PGR—migraine	9.41e-06	0.000565	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—NPS—migraine	9.41e-06	0.000565	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—HTR2C—migraine	9.23e-06	0.000554	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—HTR2A—migraine	9.06e-06	0.000544	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—EDNRA—migraine	8.98e-06	0.000539	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—HTR7—migraine	8.97e-06	0.000539	CbGpPWpGaD
Imatinib—PDGFRA—Disease—MTHFR—migraine	8.96e-06	0.000538	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—CACNA1A—migraine	8.8e-06	0.000528	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—NOTCH3—migraine	8.75e-06	0.000525	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—CALCA—migraine	8.64e-06	0.000519	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—CACNA1A—migraine	8.59e-06	0.000516	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—NOTCH4—migraine	8.26e-06	0.000496	CbGpPWpGaD
Imatinib—KIT—Immune System—FOS—migraine	8.21e-06	0.000493	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—TGFBR2—migraine	8.16e-06	0.00049	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—CACNA1A—migraine	8.1e-06	0.000486	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—HTR7—migraine	8.08e-06	0.000485	CbGpPWpGaD
Imatinib—PDGFRB—Disease—MTHFR—migraine	8.07e-06	0.000485	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—ESR1—migraine	8.04e-06	0.000483	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—CACNA1A—migraine	8.03e-06	0.000482	CbGpPWpGaD
Imatinib—LCK—Disease—TGFBR2—migraine	7.98e-06	0.000479	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—HTR1B—migraine	7.97e-06	0.000478	CbGpPWpGaD
Imatinib—PDGFRA—Immune System—FOS—migraine	7.78e-06	0.000467	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—TGFBR2—migraine	7.73e-06	0.000464	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—HTR1A—migraine	7.67e-06	0.00046	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—PGR—migraine	7.55e-06	0.000453	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—TAC1—migraine	7.55e-06	0.000453	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—NPS—migraine	7.55e-06	0.000453	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—HTR2C—migraine	7.41e-06	0.000445	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—EDNRA—migraine	7.21e-06	0.000433	CbGpPWpGaD
Imatinib—ABL1—Developmental Biology—TNF—migraine	7.13e-06	0.000428	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—NOTCH3—migraine	7.02e-06	0.000422	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—FOS—migraine	7.01e-06	0.000421	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—TGFBR2—migraine	6.96e-06	0.000418	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—CALCA—migraine	6.94e-06	0.000416	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—CACNA1A—migraine	6.86e-06	0.000412	CbGpPWpGaD
Imatinib—ABL1—Immune System—FOS—migraine	6.83e-06	0.00041	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—HTR2A—migraine	6.64e-06	0.000399	CbGpPWpGaD
Imatinib—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—migraine	6.58e-06	0.000395	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—HTR7—migraine	6.49e-06	0.000389	CbGpPWpGaD
Imatinib—LCK—Disease—MTHFR—migraine	6.48e-06	0.000389	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—HTR2A—migraine	6.28e-06	0.000377	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—ESR1—migraine	5.89e-06	0.000354	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—HTR2A—migraine	5.66e-06	0.00034	CbGpPWpGaD
Imatinib—LCK—Immune System—FOS—migraine	5.62e-06	0.000337	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—TGFBR2—migraine	5.59e-06	0.000335	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—ESR1—migraine	5.58e-06	0.000335	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—CACNA1A—migraine	5.29e-06	0.000318	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—MTHFR—migraine	5.26e-06	0.000316	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—MTHFR—migraine	5.21e-06	0.000313	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—MTHFR—migraine	5.2e-06	0.000312	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—MTHFR—migraine	5.05e-06	0.000303	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—ESR1—migraine	5.03e-06	0.000302	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—MTHFR—migraine	4.85e-06	0.000291	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—HTR2A—migraine	4.54e-06	0.000273	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—ESR1—migraine	4.03e-06	0.000242	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—MTHFR—migraine	3.77e-06	0.000226	CbGpPWpGaD
Imatinib—ALB—Metabolism—MTHFR—migraine	3.24e-06	0.000195	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—MTHFR—migraine	2.91e-06	0.000175	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—MTHFR—migraine	2.84e-06	0.000171	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—MTHFR—migraine	2.68e-06	0.000161	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—MTHFR—migraine	2.66e-06	0.000159	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—MTHFR—migraine	2.27e-06	0.000136	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—MTHFR—migraine	1.75e-06	0.000105	CbGpPWpGaD
